Business
Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners ("AIP"), an operationally-oriented industrials investor, in an all-cash transaction that values Avanos at an enterprise value of approximately $1.272 billion.
About this update from Avanos Medical, Inc.
[{"type":"text","content":"Avanos Stockholders To Receive $25.00 Per Share in Cash ","length":55,"tagName":"p","attribs":{}},{"type":"text","content":"ALPHARETTA, Ga. and NEW YORK, April 14, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners ("AIP"), an operationally-oriented industrials investor, in an all-cash transaction that values Avanos at an enterprise value of approximately $1.272 billion.","length":427,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Avanos Medical Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Avanos Medical Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":65,"url":"https://media.zenfs.com/en/prnewswire.com/a3171dfd9d9d08106baabe2b965e0542"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dRcJZtPDKdmq0wf7fMJHLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTExNQ--/https://media.zenfs.com/en/prnewswire.com/a3171dfd9d9d08106baabe2b965e0542","width":400,"height":65}},"href":"https://mma.prnewswire.com/media/713850/Avanos_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Under the terms of the agreement, Avanos stockholders will receive $25.00 per share in cash for each share of common stock they own. The per share purchase price represents a premium of approximately 72.1% to the Company's closing stock price on April 13, 2026, the last full trading day prior to the announcement of the transaction, and an 82.8% premium to the Company's 30-day volume-weighted average share price for the period ended April 13, 2026.","length":459,"tagName":"p"},{"type":"text","content":"Gary Blackford, Avanos Board chair, said, "Our agreement with AIP is a milestone for Avanos that reflects the strong momentum across the business. After careful consideration alongside our independent advisors, we are confident this agreement with AIP represents the right path forward for Avanos and its stockholders. The Board believes this transaction will maximize value for stockholders, create exciting new opportunities for employees, and best position Avanos for long‑term growth and success."","length":511,"tagName":"p"},{"type":"text","content":"David Pacitti, Avanos' chief executive officer,...